retatrutide triple agonist obesity trial Retatrutide—A Game Changer in Pharmacotherapy retatrutide triple agonist glp-1 gip

Top concerns with using GLP-1s for weight loss are predatory pharmaceutical marketing practices (70%), supply chain issues for diabetes patients (63%), and prescribing behavior

Emerging data also suggest potential renoprotective effects, offering hope for managing or preventing CKD in patients with diabetes or hypertension

We know that it may not be indicated for every MASLD patient, but I think eventually, having multiple options, could be a really powerful option for some.

Safety analysis of compounded GLP-1 receptor agonists: A pharmacovigilance study using the FDA adverse event reporting system

El volumen de distribucin es relativamente bajo, consistente con un pptido restringido al compartimento vascular y tejidos altamente perfundidos